Home
>
National Drug Code (NDC)
>
RECOMBINATE
RECOMBINATE - 0944-2845-10 - (Antihemophilic Factor Recombinant)
Drug Information of RECOMBINATE
| Product NDC: | 0944-2845 |
| Proprietary Name: | RECOMBINATE |
| Non Proprietary Name: | Antihemophilic Factor Recombinant |
| Active Ingredient(s): | & nbsp; Antihemophilic Factor Recombinant |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RECOMBINATE
| Product NDC: | 0944-2845 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103375 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100310 |
Package Information of RECOMBINATE
| Package NDC: | 0944-2845-10 |
| Package Description: | 1 KIT in 1 CARTON (0944-2845-10) * 10 mL in 1 VIAL, GLASS (0944-2835-01) * 5 mL in 1 VIAL, GLASS (52919-003-08) |
NDC Information of RECOMBINATE
| NDC Code | 0944-2845-10 |
| Proprietary Name | RECOMBINATE |
| Package Description | 1 KIT in 1 CARTON (0944-2845-10) * 10 mL in 1 VIAL, GLASS (0944-2835-01) * 5 mL in 1 VIAL, GLASS (52919-003-08) |
| Product NDC | 0944-2845 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Antihemophilic Factor Recombinant |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20100310 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
